SLAMF6 and 2B4: roles and modes of action in normal immunity and cancer immunotherapy

SLAMF6和2B4：在正常免疫和癌症免疫治疗中的作用和作用方式

• 批准号: 343109
• 负责人: Veillette Andr
• 金额: --
• 依托单位: Institut de recherches cliniques de Montral
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2016
• 资助国家: 加拿大
• 起止时间: 2016-02-01 至 2019-02-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=343109&lang=en
• 关键词: Cancer; Immune Cell Receptors; Melanoma; Mouse Models; Nk Cells; Signaling; T Cells

Recent results obtained in the clinic show that improving the function of the immune system, by so called "immunotherapy", can greatly improve the ability to treat cancer in humans. New drugs (such as antibodies) that block the function of certain types o

最近在临床上获得的结果表明，通过改善免疫系统功能，即所谓的“免疫疗法”，可以极大地提高人类治疗癌症的能力。阻断某些类型药物功能的新药(如抗体)